Insilico Medicine Secures $110 Million in Series E Funding to Advance AI Platform
Insilico Medicine, a biopharmaceutical company focused on generative artificial intelligence, today announced the successful completion of a $110 million Series E financing round. The round was led by a private equity fund under Value Partners Group (HKG:0806), Pudong New Area Investment, Shanghai Pudong Development Bank Group, Xicheng Capital, and Yixing Guokong. Several new investors focused on the industry and technology sectors also participated, alongside continued support from existing investors.
%20--%3e%3cdefs%3e%3cstyle%3e%20.st0%20{%20fill:%20%23061b40;%20}%20.st1%20{%20fill:%20%23306af1;%20}%20.st2%20{%20fill:%20%235ce5cf;%20}%20%3c/style%3e%3c/defs%3e%3cg%3e%3cpath%20class='st0'%20d='M55,10.5h9v3h-9v9h12V7.5h-12v3ZM64,19.5h-6v-3h6v3Z'/%3e%3cpolygon%20class='st0'%20points='69%2016.5%2078%2016.5%2078%2019.5%2069%2019.5%2069%2022.5%2081%2022.5%2081%2013.5%2072%2013.5%2072%2010.5%2081%2010.5%2081%207.5%2069%207.5%2069%2016.5'/%3e%3cpolygon%20class='st0'%20points='95%2010.5%2095%207.5%2083%207.5%2083%2022.5%2095%2022.5%2095%2019.5%2086%2019.5%2086%2016.5%2095%2016.5%2095%2013.5%2086%2013.5%2086%2010.5%2095%2010.5'/%3e%3cpath%20class='st0'%20d='M40,1.5v21h11.6l1.4-1.4v-7.6h0c0,0-1.4-1.5-1.4-1.5l1.4-1.4V2.9l-1.4-1.4h-11.6ZM50,19.5h-7v-6h7v6ZM50,10.5h-7v-6h7v6Z'/%3e%3c/g%3e%3cpath%20class='st1'%20d='M23.1,24L14.7,4.8l-4.9,11.2h3.8l-1.8,4H3.3L12.1,0H2C.9,0,0,.9,0,2v20c0,1.1.9,2,2,2h21.1Z'/%3e%3cpath%20class='st2'%20d='M34,0h-16.8l10.6,24h6.2c1.1,0,2-.9,2-2V2C36,.9,35.1,0,34,0ZM32.5,20h-4V4h4v16Z'/%3e%3c/svg%3e)
'%3e%3cpath%20d='M55.2622%2038L48.2289%2022L44.1206%2031.3333H47.2539L45.7872%2034.6667H38.7622L46.0956%2018H37.6706C36.7539%2018%2036.0039%2018.75%2036.0039%2019.6667V36.3333C36.0039%2037.25%2036.7539%2038%2037.6706%2038H55.2622Z'%20fill='white'/%3e%3cpath%20d='M64.3368%2018H50.3535L59.1535%2038H64.3368C65.2535%2038%2066.0035%2037.25%2066.0035%2036.3333V19.6667C66.0035%2018.75%2065.2535%2018%2064.3368%2018ZM63.0868%2034.6667H59.7535V21.3333H63.0868V34.6667Z'%20fill='%23FFCC66'/%3e%3cpath%20d='M89.3379%2026.75V29.25H81.8379V36.75H91.8379V24.25H81.8379V26.75H89.3379ZM84.3379%2034.25V31.75H89.3379V34.25H84.3379Z'%20fill='white'/%3e%3cpath%20d='M103.504%2036.75V29.25H96.0039V26.75H103.504V24.25H93.5039V31.75H101.004V34.25H93.5039V36.75H103.504Z'%20fill='white'/%3e%3cpath%20d='M115.17%2026.75V24.25H105.17V36.75H115.17V34.25H107.67V31.75H115.17V29.25H107.67V26.75H115.17Z'%20fill='white'/%3e%3cpath%20d='M80.1712%2029.25V29.175L78.9962%2028L80.1712%2026.825V20.425L78.9962%2019.25H69.3379V36.75H78.9962L80.1712%2035.575V29.25ZM77.6712%2034.25H71.8379V29.25H77.6712V34.25ZM77.6712%2026.75H71.8379V21.75H77.6712V26.75Z'%20fill='white'/%3e%3c/g%3e%3cg%20clip-path='url(%23clip1_644_3948)'%3e%3cpath%20d='M169.59%2022.9827L169.59%2023.6491H177.409L168.175%2032.8822L169.118%2033.8248L178.351%2024.5917L178.352%2032.4106H179.685V22.3164L179.018%2022.3157H169.59V22.9827Z'%20fill='white'/%3e%3c/g%3e%3cdefs%3e%3cclipPath%20id='clip0_644_3948'%3e%3crect%20width='80'%20height='20'%20fill='white'%20transform='translate(36%2018)'/%3e%3c/clipPath%3e%3cclipPath%20id='clip1_644_3948'%3e%3crect%20width='20'%20height='20'%20fill='white'%20transform='translate(164%2018)'/%3e%3c/clipPath%3e%3c/defs%3e%3c/svg%3e)
